MEDITOXIN 200UMEDITOXIN 200U MEDITOXIN 200U is a high quality formulation of botulinum toxin type A, developed by Medy Tox Korea and approved by the Korea Drug Administration (KDA) in 2004. Known for its effectiveness and safety, MEDITOXIN provides targeted muscle relaxation by temporarily blocking the release of acetylcholine at the neuromuscular junction. This allows for both cosmetic and therapeutic applications with results lasting approximately 46 months. Key